Grigeo (GRG1L) Q2 2025 earnings summary

Executive summary

• Revenue rose by EUR 12.4 million (12%) year-over-year to EUR 116.7 million for the first half of 2025.

• EBITDA declined by EUR 0.9 million (5%) and profit before tax (EBT) fell by EUR 2.3 million (19%) compared to the same period last year.

Financial highlights

• Net profit for the period was EUR 9.1 million, down from EUR 10.0 million year-over-year.

• Gross margin decreased to 21.0% from 23.4% year-over-year.

• Adjusted EBITDA for the period was EUR 15.8 million, compared to EUR 16.7 million in the prior year.

• Earnings per share were EUR 0.069 (basic) and EUR 0.068 (diluted), both lower than the previous year.

• Cash and cash equivalents at period end were EUR 11.7 million, down from EUR 14.0 million at year-end 2024.

Outlook and guidance

• Plans to invest EUR 106 million in the tissue business were announced after the reporting period.